Discontinuation report HYCAMTIN

Last updated on 2019-06-11 History
Report ID 8129
Drug Identification Number 02231116
Brand name HYCAMTIN
Common or Proper name Hycamtin4mg/Vials 5's
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOPOTECAN
Strength(s) 4MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 4mg x 5
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-05-31
Actual discontinuation date 2019-06-10
Remaining supply date 2019-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Inventory on hand - expiration date 30.11.2019.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-06-11 English Compare
v17 2019-06-10 French Compare
v16 2019-06-10 English Compare
v15 2019-06-10 English Compare
v14 2019-03-08 French Compare
v13 2019-03-08 English Compare
v12 2019-02-11 French Compare
v11 2019-02-11 English Compare
v10 2019-02-11 English Compare
v9 2017-09-26 French Compare
v8 2017-09-26 English Compare
v7 2017-06-15 French Compare
v6 2017-06-15 English Compare
v5 2017-04-28 French Compare
v4 2017-04-28 English Compare
v3 2017-04-26 French Compare
v2 2017-04-26 French Compare
v1 2017-04-26 English Compare

Showing 1 to 18 of 18